Antineutrophil cytoplasmic antibody-associated vasculitis associated with Epstein-Barr virus infection: A case report and review of the literature

Infection

Volumn 42, Issue 3, 2014, Pages 591-594

  Xu, P ^a   Lin, S ^a   Wei, L ^a   Shang, W ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Antineutrophil cytoplasmic antibody; Epstein Barr virus; Infection; Myeloperoxidase; Vasculitis

Indexed keywords

C REACTIVE PROTEIN; GANCICLOVIR; HEMOGLOBIN; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; SERUM ALBUMIN; VIRUS CAPSID ANTIGEN; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN M; NEUTROPHIL CYTOPLASMIC ANTIBODY; VIRUS ANTIBODY;

ACUTE KIDNEY FAILURE; ADOLESCENT; ANCA ASSOCIATED VASCULITIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CASE REPORT; CREATININE BLOOD LEVEL; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; FOLLOW UP; HEMATURIA; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; NORMOCHROMIC NORMOCYTIC ANEMIA; PROTEINURIA; RELAPSE; URINALYSIS; URINE SEDIMENT; BLOOD; COMPLICATION; EPSTEIN BARR VIRUS; IMMUNOLOGY; KIDNEY DISEASES; ORAL DRUG ADMINISTRATION; PATHOLOGY; VASCULITIS;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN M; KIDNEY DISEASES; METHYLPREDNISOLONE; VASCULITIS;

EID: 84901652386     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-014-0606-4     Document Type: Article

References (20)

1. Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883-96.
2. Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628-36.
3. Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum. 1995;38:633-7.
4. Sihvonen S, Korpela M, Mustila A, Mustonen J. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005;32:2089-94. (Pubitemid 41587850)
5. Spadaro M, Amendolea MA, Mazzucconi MG, et al. Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler. 1999;5:121-5. (Pubitemid 29186830)
6. Cil T, Altintas A, Isikdogan A, Batun S. Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin's and non-Hodgkin lymphoma: a single center experience. Int J Hematol. 2009;90:52-7.
7. Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006;101:2410-22. (Pubitemid 44477569)
8. Nishiya K, Chikazawa H, Hashimoto K, Miyawaki S. Antineutrophil cytoplasmic antibody in patients with primary Sjögren's syndrome. Clin Rheumatol. 1999;18:268-71. (Pubitemid 29284732)
9. Ruffatti A, Sinico RA, Radice A, et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol. 2002;29:918-23. (Pubitemid 34493493)
10. De Riva V, Celadin M, Pittoni M, Plebani M, Angeli P. What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease? Liver Int. 2009;29:865-70.
11. Pietravalle P, Monteleone G, Morano S, et al. Antineutrophil cytoplasmic antibodies are present in long standing type 1 diabetics but do not correlate with selective proteinuria. J Autoimmun. 1996;9:113-7. (Pubitemid 26141896)
12. Lidar M, Lipschitz N, Langevitz P, et al. Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci. 2009;1173:649-57.
13. Daikeler T, Erley C, Mohren M, et al. Fever and increasing cANCA titre after kidney and autologous stem cell transplantation for Wegener's granulomatosis. Ann Rheum Dis. 2005;64:646-7. (Pubitemid 40469102)
14. Schned AR, Ornvold K, Tsongalis GJ, Chobanian MC. Fatal relapse of ANCA-associated glomerulonephritis triggered by successive Epstein-Barr and varicella zoster virus infections. Am J Kidney Dis. 2006;47:915-22.
15. Anders HJ, Vielhauer V, Eis V, et al. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 2004;18:534-6.
16. Allam R, Pawar RD, Kulkarni OP, et al. Viral 5′-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses. Eur J Immunol. 2008;38:3487-98.
17. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416:603-7. (Pubitemid 34406754)
18. Anders HJ, Lichtnekert J, Allam R. Interferon-alpha and -beta in kidney inflammation. Kidney Int. 2010;77:848-54.
19. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005;23:307-36. (Pubitemid 40563172)
20. Xu PC, Cui Z, Chen M, Hellmark T, Zhao MH. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. Rheumatology (Oxford). 2011;50:1236-43.